Go Pro

Stock Analyst Initiations

Track the latest stock analyst initiations, newly initiated coverage, and first-time analyst ratings in this regularly updated list of analyst recommendations. This page compiles new initiations, including initial stock ratings, buy/hold/sell recommendations, and price targets, so you can monitor all recent coverage openings across the market.

CompanyActionBrokerageAnalystCurrent PricePrice TargetRatingDetails
Adobe Inc. stock logo
ADBE
Adobe
Initiated by $234.74
-1.1%
$300.00Outperform
Adobe Inc. stock logo
ADBE
Adobe
Initiated by$234.74
-1.1%
$300.00Outperform
Aercap Holdings N.V. stock logo
AER
Aercap
Initiated by$148.47
+1.0%
$173.00Buy
Anthem, Inc. stock logo
ANTX
Anthem
Initiated by$4.80
+2.6%
$9.00Buy
Apollo Global Management Inc. stock logo
APO
Apollo Global Management
Initiated by$118.28
-1.8%
$145.00Buy
Apollo Global Management Inc. stock logo
APO
Apollo Global Management
Initiated by $118.28
-1.8%
$145.00Buy
AtlasClear Holdings, Inc. stock logo
ATCH
AtlasClear
Initiated by $0.19
+1.4%
Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
Initiated by $221.64
-3.6%
$310.00Outperform
BP p.l.c. stock logo
BP
BP
Initiated by$42.04
+0.3%
$51.00NeutralOutperform
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
Initiated by$16.50
+4.9%
$18.00Buy
Buy this stock today (Ad)

Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to move out of overpriced AI stocks before the tech trade breaks down and into lesser-known names with real potential to challenge the Mag 7. One pick he calls 'an upgrade to Tesla stock' is a little-known company that just inked a partnership with Nvidia, positioning it ahead of Tesla in the autonomous vehicle race.tc pixel

Get the name, ticker, and full Hotlist before markets open
Citizens Holding stock logo
CIZN
Citizens
Initiated by $9.96
-0.4%
Market Outperform
Crane stock logo
CR
Crane
Initiated by$217.90
+0.2%
$253.00Outperform
Salesforce Inc. stock logo
CRM
Salesforce
Initiated by$173.82
+1.8%
$165.00Hold
DPC
DPC
Initiated by$45.40
-1.9%
$47.00Equal Weight
DPC
DPC
Initiated by$45.40
-1.9%
$53.50Buy
DPC
DPC
Initiated by$45.40
-1.9%
$53.00Outperform
DPC
DPC
Initiated by$45.40
-1.9%
$56.00Buy
First American Financial Corporation stock logo
FAF
First American Financial
Initiated by $71.72
-1.8%
Buy
Sensei Biotherapeutics, Inc. stock logo
FTH
Sensei Biotherapeutics
Initiated by$28.19
+9.0%
$51.00Outperform
Gloo Holdings stock logo
GLOO
Gloo
Initiated by$3.40
+4.0%
$8.00Outperform
Gloo Holdings stock logo
GLOO
Gloo
Initiated by $3.40
+4.0%
Outperform
Honeywell Aerospace stock logo
HONA
Honeywell Aerospace
Initiated by$202.47
-4.3%
$231.00Neutral
Insmed, Inc. stock logo
INSM
Insmed
Initiated by $107.02
-1.2%
$192.00Outperform
Kinetik Holdings Inc. stock logo
KNTK
Kinetik
Initiated by $51.11
+1.7%
$57.00Buy
LB Pharmaceuticals Inc stock logo
LBRX
LB Pharmaceuticals
Initiated by $30.90
-1.6%
$46.00Outperform
Moog Inc. stock logo
MOG.A
Moog
Initiated by$396.13
+0.7%
$520.00Overweight
Maplight Therapeutics, Inc. stock logo
MPLT
Maplight Therapeutics
Initiated by $35.99
-5.0%
$46.00Outperform
Microsoft Corporation stock logo
MSFT
Microsoft
Initiated by$402.29
+2.2%
$535.00Outperform
Microsoft Corporation stock logo
MSFT
Microsoft
Initiated by $402.29
+2.2%
$535.00Outperform
NewAmsterdam Pharma Company N.V. stock logo
NAMS
NewAmsterdam Pharma
Initiated by $29.67
-6.3%
$58.00Outperform
Netflix, Inc. stock logo
NFLX
Netflix
Initiated by $67.60
-2.0%
Outperform
NextNav Inc. stock logo
NN
NextNav
Initiated by $12.84
-1.7%
$22.00Buy
NN, Inc. stock logo
NNBR
NN
Initiated by$3.48
+9.4%
$7.00Buy
ServiceNow, Inc. stock logo
NOW
ServiceNow
Initiated by$104.90
+1.6%
$72.00Underperform
Enpro Inc. stock logo
NPO
Enpro
Initiated by$325.72
+0.9%
$420.00Overweight
Oracle Corporation stock logo
ORCL
Oracle
Initiated by$121.38
-4.0%
$145.00Hold
Oracle Corporation stock logo
ORCL
Oracle
Initiated by$121.38
-4.0%
$145.00Hold
Ralliant Corporation stock logo
RAL
Ralliant
Initiated by$69.78
-0.6%
$78.00Market Perform
Rein Therapeutics Inc. stock logo
RNTX
Rein Therapeutics
Initiated by$0.84
-2.1%
$4.00Buy
Regal Rexnord Corporation stock logo
RRX
Regal Rexnord
Initiated by$205.69
-0.5%
$286.00Buy
Ready to give options a try? Your first trade (Ticker included) -INSIDE (Ad)

Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.tc pixel

Shell PLC Unsponsored ADR stock logo
SHEL
Shell
Initiated by$86.20
-1.3%
$98.00Neutral
Soluna Holdings, Inc. stock logo
SLNH
Soluna
Initiated by$1.36
+20.4%
$4.00Buy
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
Initiated by$6.33
+7.8%
$12.00Buy
Neuronetics, Inc. stock logo
STIM
Neuronetics
Initiated by$2.02
+24.7%
$5.00Buy
Shattuck Labs, Inc. stock logo
STTK
Shattuck Labs
Initiated by$6.82
-9.4%
$16.00Outperform
Trulieve Cannabis Corp. stock logo
TRLV
Trulieve Cannabis
Initiated by$8.73
-0.7%
$15.00Overweight
Trevi Therapeutics, Inc. stock logo
TRVI
Trevi Therapeutics
Initiated by $16.77
-12.1%
$36.00Outperform
Tesla, Inc. stock logo
TSLA
Tesla
Initiated by$369.57
-3.0%
PositiveHold
TotalEnergies SE Sponsored ADR stock logo
TTE
TotalEnergies
Initiated by$81.04
-0.4%
$103.00Outperform
Universal Music Group stock logo
UMGNF
Universal Music Group
Initiated by $21.04
+2.2%
BuyNeutral
Versigent stock logo
VGNT
Versigent
Initiated by$39.97
-0.1%
$48.00Buy
Workday, Inc. stock logo
WDAY
Workday
Initiated by$147.22
+1.7%
$92.00Underperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 01:40 AM ET.

Frequently Asked Questions

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports  and conversations with company executives.

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.